Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne - CNBC.com -BoardProspects

Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne

CNBC.com May 29 2018 BoardMoves

SAN DIEGO, May 29, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT) (“Arcturus” or the “Company), a leading RNA medicines company, today announced that, as part of a settlement agreement, it has appointed four new independent directors, Dr. Peter Farrell, Mr. Andrew Sassine, Mr. James Barlow and Dr. Magda Marquet, to its Board, effective as of May 27, 2018...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- Carl Icahn: Netflix Poison-Pill Move 'Reprehensible' also published in CNBC.com
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Marissa Mayer's Huge Payday also published in CNBC.com
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Quotes
1. We are pleased to have come together to reach this very positive outcome that allows Arcturus to move forward, focused on creating substantial value for all shareholders.
Topics Mentioned
- Board of directors
- technology
- acquisition
- Corporate Governance
- Nasdaq
- NYSE
- SEC
- Europe
- Bank
- Japan
- Harvard
- Board of Trustees
- MBA
- Allergan
- Pfizer
- Johnson & Johnson
- Scripps
- Takeda
- Arcturus Therapeutics
- CEO
- Leadership
- Pharmaceutical Companies
- Communication